HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UVA sunscreens

This article was originally published in The Rose Sheet

Executive Summary

Industry coalition calls for use of "UVA protection" and "extra UVA protection" sunscreen label claims in Aug. 30 comments to FDA. The group - Schering-Plough, Johnson & Johnson, L'Oreal, Estee Lauder, Mary Kay and Bath & Body Works - supports the two-tiered UVA protection labeling designation in contrast to the "broad-spectrum" or "pass/fail" labeling allowed in the tentative final monograph. The labeling statement would depend on proportionate protection against UVA to SPF for UVB, but SPF "should retain preeminence" on packaging, the coalition notes. The group also supports in vivo testing of UVA protection efficacy by means of Protection Factor A method and/or Persistent Pigment Darkening method

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel